SGLT2-Inhibitors and cardiovascular outcomes : inferences for clinical practice

Journal Title: Journal of the Indian Medical Association - Year 2018, Vol 116, Issue 10

Abstract

Cardiovascular risk is the keyconsideration in the management of type 2 diabetes mellitus. Evolving evidence suggests possible cardiovascular protection with certain agents of the SGLT2 inhibitors (SGLT2-i) class. It is important to understand the meaning of the available evidence, for the clinical practice setting. This review attempts to interpret the finer aspects of the available evidence, for appropriate translation to practice.

Authors and Affiliations

Saptarshi Bhattacharya, Amit K Adhikary, Sudipta Mondal, Dipanjan Bandyopadhyay

Keywords

Related Articles

Anticoagulation free hemodialysis

Anticoagulant is necessary to prevent filter clotting during dialysis. Pleople who are bleeding or likely to bleed need anticoagulant free dialysis. Most centers use regional citrate anticoagulant or intermittant saline...

Parkinson’s disease : diagnosis and management

Parkinson’s disease (PD) is a chronic, progressive, neurodegenerative disorder best characterized by the motor symptoms of tremor, rigidity and bradykinesia. The presentation of PD varies based on the stage of illness an...

Suzuki classification : a useful adjunct to michel and hiatt hepatic arterial classification systems

Multidetector Computed Tomography (MDCT) allows non-invasive and accurate preoperative evaluation of hepatobiliary anatomy. Clinician is well versed with relevant hepatobiliary anatomy and can meticulously plan treatment...

A case report of Tolosa Hunt syndrome

Tolosa Hunt syndrome is a rare clinical entitycharacterized by sudden onset of painful ophthalmoplegia and prompt response to steroid therapy1. Generally it involves third, fourth and sixth cranial nerves due to the pres...

Follow up study of High Tibial Osteomy using medial open wedge Osteotomy in medial unicompartmental Osteoarthritis of knee

High Tibial Osteomy (HTO) was a very popular method to treat Osteo Arthritis (OA) Knee for years. Its suitable for treating mainly medial compartment OA of Knee. We have treated 20 Knees with genu Varum deformity with Me...

Download PDF file
  • EP ID EP616023
  • DOI -
  • Views 136
  • Downloads 0

How To Cite

Saptarshi Bhattacharya, Amit K Adhikary, Sudipta Mondal, Dipanjan Bandyopadhyay (2018). SGLT2-Inhibitors and cardiovascular outcomes : inferences for clinical practice. Journal of the Indian Medical Association, 116(10), 89-92. https://europub.co.uk/articles/-A-616023